6/13/2023 0 Comments How to you pronounce evovaxWe will continue to work closely with the US FDA on remediating the issues at our Mohali facility and will take all necessary measures to keep our facilities in full compliance to all global regulations. We are assessing the terms and practical applications of this CD. The US FDA also advised that the Mohali plant will be subject to certain terms of the consent decree (CD), filed in late January 2012 for Ranbaxy's Paonta Sahib and Dewas plants. "As you would know, on September 16, 2013, Ranbaxy received a communication from the US FDA about an import alert on its Mohali plant. The letter goes into some detail about the background of the controversy. "Since the last inspection by the US FDA at Mohali in 2012, Ranbaxy has strengthened its management, manufacturing and monitoring systems and processes, to ensure quality and compliance in all areas." "I would like to assure you that the issues that were raised by the US FDA in 2012 have been addressed and we have taken stringent steps to ensure that we meet all US FDA concerns," says the letter. ![]() ![]() Ranbaxy CEO Arun Sawhney has now written a detailed mail to editors providing his perspective on the matter and outlining the road ahead. Business Today has been exhaustively covering the developments. ![]() Products from three of its manufacturing units - at Paonta Sahib, Dewas and most recently, Mohali - have drawn the ire of the US Food and Drugs Administration (US FDA). Leading pharmaceutical company Ranbaxy has been in the news for all the wrong reasons for many months now.
0 Comments
Leave a Reply. |